NeoStem, Inc. Appoints Douglas W. Losordo as Chief Medical Officer

Published: Aug 06, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

NEW YORK, Aug. 6, 2013 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq:NBS) ("NeoStem" or the "Company"), a leader in the emerging cellular therapy market, announced today the appointment of Douglas W. Losordo, MD, FACC, FAHA, as Chief Medical Officer of the Company. Dr. Losordo is a leader in cell therapy research and a renowned cardiologist. Most recently, Dr. Losordo was Vice President, New Therapies Development, Regenerative Medicine and Baxter Ventures at Baxter International.

Help employers find you! Check out all the jobs and post your resume.

Back to news